Genetic insights in Alzheimer's disease
暂无分享,去创建一个
Christine Van Broeckhoven | Kristel Sleegers | C. Broeckhoven | K. Sleegers | K. Bettens | Karolien Bettens
[1] D. Hernandez,et al. Alzheimer Risk Variant CLU and Brain Function During Aging , 2013, Biological Psychiatry.
[2] A. Goate,et al. Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe , 2003, Human mutation.
[3] R. Tanzi,et al. Role of common and rare APP DNA sequence variants in Alzheimer disease , 2012, Neurology.
[4] Hilkka Soininen,et al. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations , 2011, Neurobiology of Aging.
[5] Lesley Jones,et al. Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease. , 2010, Biochimica et biophysica acta.
[6] Eric M Reiman,et al. Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast , 2011, Science.
[7] S. Hunt,et al. Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. , 1997, Molecular biology of the cell.
[8] K. Sleegers,et al. SORL1 is genetically associated with increased risk for late‐onset Alzheimer disease in the Belgian population , 2008, Human mutation.
[9] A. Singleton,et al. Repeat expansion in C9ORF72 in Alzheimer's disease. , 2012, The New England journal of medicine.
[10] K. Lunetta,et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. , 2010, Archives of neurology.
[11] M. Daly,et al. Common SNPs in HMGCR in Micronesians and Whites Associated With LDL-Cholesterol Levels Affect Alternative Splicing of Exon13 , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[12] P. Bosco,et al. Erratum: Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease (Molecular Psychiatry (2013) 18 (521) DOI: 10.1038/mp.2012.75)) , 2013 .
[13] S. Langdon,et al. Structural organization of the human MS4A gene cluster on Chromosome 11q12 , 2001, Immunogenetics.
[14] Tanya M. Teslovich,et al. Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.
[15] Michael Weiner,et al. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort , 2010, NeuroImage.
[16] F. Jessen,et al. Association of the Alzheimer's disease clusterin risk allele with plasma clusterin concentration. , 2011, Journal of Alzheimer's disease : JAD.
[17] D. Campion,et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy , 2006, Nature Genetics.
[18] D A Bennett,et al. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory , 2012, Neurology.
[19] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[20] Thomas W. Mühleisen,et al. Hippocampal Function in Healthy Carriers of the CLU Alzheimer's Disease Risk Variant , 2011, The Journal of Neuroscience.
[21] J. Wiszniewska,et al. Olfactory copy number association with age at onset of Alzheimer disease , 2011, Neurology.
[22] J. Ioannidis,et al. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study , 2011, The Lancet Neurology.
[23] Michelle K. Lupton,et al. Deep Sequencing of the Nicastrin Gene in Pooled DNA, the Identification of Genetic Variants That Affect Risk of Alzheimer's Disease , 2011, PloS one.
[24] S. Potkin,et al. Genome-wide association study of CSF biomarkers Aβ1-42, t-tau, and p-tau181p in the ADNI cohort , 2010, Neurology.
[25] C. Ferri,et al. World Alzheimer Report 2009 , 2009 .
[26] I. Walker,et al. SP‐40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges , 1992, FEBS letters.
[27] Alzheimer's Disease Neuroimaging Initiative,et al. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease , 2011, Molecular Psychiatry.
[28] L. Tan,et al. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease , 2010, Brain Research.
[29] W. Wakarchuk,et al. Distinct Endocytic Mechanisms of CD22 (Siglec-2) and Siglec-F Reflect Roles in Cell Signaling and Innate Immunity , 2007, Molecular and Cellular Biology.
[30] I. Lieberburg,et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.
[31] S. Bohlander,et al. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. , 1999, Molecular biology of the cell.
[32] Margaret A. Pericak-Vance,et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression , 2012, Neurology.
[33] Eileen Daly,et al. Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer’s disease , 2008, Journal of Neurology.
[34] L. Farrer,et al. Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. , 2003, Human molecular genetics.
[35] M Mancuso,et al. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease , 2012, Molecular Psychiatry.
[36] Kristopher L. Nazor,et al. Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells , 2012, Nature.
[37] J. Shulman,et al. Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. , 2011, American journal of human genetics.
[38] M. J. Fresnadillo Martínez,et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions , 2010, Nature Genetics.
[39] K. Blennow,et al. Clusterin in cerebrospinal fluid: Analysis of carbohydrates and quantification of native and glycosylated forms , 2006, Neurochemistry International.
[40] B. Maher. Personal genomes: The case of the missing heritability , 2008, Nature.
[41] Guillén Fernández,et al. CR1 genotype is associated with entorhinal cortex volume in young healthy adults , 2011, Neurobiology of Aging.
[42] David B Goldstein,et al. Genome-wide scan of copy number variation in late-onset Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[43] Dolores Corella,et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.
[44] G. Corthals,et al. A Cortactin-CD2-associated Protein (CD2AP) Complex Provides a Novel Link between Epidermal Growth Factor Receptor Endocytosis and the Actin Cytoskeleton* , 2003, Journal of Biological Chemistry.
[45] E. Ingelsson,et al. Genome‐wide and gene‐based association implicates FRMD6 in alzheimer disease , 2012, Human mutation.
[46] L. Hazrati,et al. Genetic association of CR1 with Alzheimer's disease: A tentative disease mechanism , 2012, Neurobiology of Aging.
[47] James T Becker,et al. The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease , 2011, Genome Medicine.
[48] Susan M Resnick,et al. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. , 2010, Archives of general psychiatry.
[49] E. Lander,et al. The mystery of missing heritability: Genetic interactions create phantom heritability , 2012, Proceedings of the National Academy of Sciences.
[50] V. Pankratz,et al. Replication of CLU, CR1, and PICALM associations with alzheimer disease. , 2010, Archives of neurology.
[51] Hans Lehrach,et al. The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels. , 2011, Archives of general psychiatry.
[52] Kewei Chen,et al. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. , 2010, Human molecular genetics.
[53] S. Johnston,et al. Neural hyperactivation in carriers of the Alzheimer's risk variant on the clusterin gene , 2011, European Neuropsychopharmacology.
[54] F. Pasquier,et al. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites , 2011, Molecular Psychiatry.
[55] B. Strooper,et al. Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms , 2006, Journal of neurochemistry.
[56] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.
[57] Y. Pawitan,et al. Strategies and issues in the detection of pathway enrichment in genome-wide association studies , 2009, Human Genetics.
[58] P. S. St George-Hyslop,et al. The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample. , 2002, American journal of human genetics.
[59] G. Rouleau,et al. A Mutation that Creates a Pseudoexon in SOD1 Causes Familial ALS , 2009, Annals of human genetics.
[60] Jason J. Corneveaux,et al. A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline. , 2012, Human molecular genetics.
[61] M. Carrasquillo,et al. Functional and genetic analysis of haplotypic sequence variation at the nicastrin genomic locus , 2012, Neurobiology of Aging.
[62] F. Jessen,et al. A Pan-European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats , 2012, Human mutation.
[63] Sonja W. Scholz,et al. Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.
[64] P. S. St George-Hyslop,et al. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. , 2011, Archives of neurology.
[65] P. Bosco,et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance , 2011, Molecular Psychiatry.
[66] G. Schellenberg,et al. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study , 2010, BMC neurology.
[67] David B Goldstein,et al. Screening the human exome: a comparison of whole genome and whole transcriptome sequencing , 2010, Genome Biology.
[68] C. Weickert,et al. Role of ATP‐binding cassette transporters in brain lipid transport and neurological disease , 2008, Journal of neurochemistry.
[69] Margaret A. Pericak-Vance,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease , 1997 .
[70] Nick C Fox,et al. Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .
[71] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[72] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[73] P. S. St George-Hyslop,et al. Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk , 2012, Molecular Neurodegeneration.
[74] P. Linsel-Nitschke,et al. ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages , 2006, The Journal of cell biology.
[75] K. Sleegers,et al. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. , 2007, Archives of neurology.
[76] C. van Broeckhoven,et al. A novel presenilin 1 mutation associated with Pick's disease but not β‐amyloid plaques , 2004, Annals of neurology.
[77] G. Schellenberg,et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.
[78] B. Dubois,et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. , 1999, American journal of human genetics.
[79] Albert Hofman,et al. Plasma clusterin and the risk of Alzheimer disease. , 2011, JAMA.
[80] Jason J. Corneveaux,et al. CR1 is associated with amyloid plaque burden and age‐related cognitive decline , 2011, Annals of neurology.
[81] Claudia Manzoni,et al. A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis , 2009, Science.
[82] D. Campion,et al. APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[83] Miguel Ángel Martínez,et al. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. , 1997, American journal of human genetics.
[84] Nick C Fox,et al. Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.
[85] Sudha Seshadri,et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.
[86] S. DeKosky,et al. Association of CLU and PICALM variants with Alzheimer's disease , 2012, Neurobiology of Aging.
[87] M. Mattson,et al. Evidence for CALM in Directing VAMP2 Trafficking , 2008, Traffic.
[88] J. Rommens,et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.
[89] K. Sleegers,et al. Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. , 2006, American journal of human genetics.
[90] K. Sleegers,et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. , 2006, Brain : a journal of neurology.
[91] Nick C Fox,et al. Genetic Variability in CLU and Its Association with Alzheimer's Disease , 2010, PloS one.
[92] Hugo Vanderstichele,et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.
[93] Yasuyoshi Watanabe,et al. A new amyloid β variant favoring oligomerization in Alzheimer's‐type dementia , 2008, Annals of neurology.
[94] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[95] J. Haines,et al. Identification and Confirmation of an Exonic Splicing Enhancer Variation in Exon 5 of the Alzheimer Disease Associated PICALM Gene , 2012, Annals of human genetics.
[96] Olle Melander,et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus , 2010, Nature.
[97] Margaret A. Pericak-Vance,et al. Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants , 2012, PLoS genetics.
[98] M. Nalls,et al. Extended tracts of homozygosity identify novel candidate genes associated with late-onset Alzheimer’s disease , 2009, neurogenetics.
[99] F. Marrosu,et al. C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population , 2012, Neurobiology of Aging.
[100] N. Jahanshad,et al. Common Alzheimer's Disease Risk Variant Within the CLU Gene Affects White Matter Microstructure in Young Adults , 2011, The Journal of Neuroscience.
[101] C. van Broeckhoven,et al. Mean age‐of‐onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40 , 2006, Human mutation.
[102] R. Khera,et al. Complement Receptor 1: Disease associations and therapeutic implications , 2008, Molecular Immunology.
[103] K. Sleegers,et al. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease , 2008, Neurology.
[104] K. Lunetta,et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.
[105] E. Wijsman,et al. Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE , 2011, PLoS genetics.
[106] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[107] A. Fagan,et al. Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease , 2011, PloS one.
[108] A. Singleton,et al. Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease , 2012, Neurobiology of Aging.
[109] Sandro Sorbi,et al. Meta-analysis of the association between variants in SORL1 and Alzheimer disease. , 2011, Archives of neurology.
[110] H. Okano,et al. Modeling familial Alzheimer's disease with induced pluripotent stem cells. , 2011, Human molecular genetics.
[111] S. Bassett,et al. Alzheimer's risk variants in the clusterin gene are associated with alternative splicing , 2011, Translational Psychiatry.
[112] Marisa O. Hollinshead,et al. Identification of common variants associated with human hippocampal and intracranial volumes , 2012, Nature Genetics.
[113] A. A. Romanovsky,et al. Putative dual role of ephrin‐Eph receptor interactions in inflammation , 2006, IUBMB life.
[114] D. G. Clark,et al. Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.
[115] B Croisile,et al. High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease , 2012, Molecular Psychiatry.
[116] V. Pankratz,et al. Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study , 2011, Molecular Neurodegeneration.
[117] T. Suuronen,et al. Clusterin: A forgotten player in Alzheimer's disease , 2009, Brain Research Reviews.
[118] N. Matsumoto,et al. Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer disease , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[119] Holly Soares,et al. Meta-Analysis for Genome-Wide Association Study Identifies Multiple Variants at the BIN1 Locus Associated with Late-Onset Alzheimer's Disease , 2011, PloS one.
[120] Ole A. Andreassen,et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.
[121] A. Hofman,et al. Serum clusterin levels are not increased in presymptomatic Alzheimer's disease. , 2011, Journal of proteome research.
[122] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[123] L. Kiemeney,et al. Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.
[124] Nick C Fox,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.
[125] D. G. Ferguson,et al. A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. , 1990, The Journal of biological chemistry.
[126] Mert Sabuncu,et al. Genetic variation and neuroimaging measures in Alzheimer disease. , 2010, Archives of neurology.
[127] D. Drachman,et al. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia , 2007, Clinical genetics.
[128] Michelle K. Lupton,et al. No evidence that extended tracts of homozygosity are associated with Alzheimer's disease , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[129] D. Pollen,et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.
[130] Yusuke Nakamura,et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.
[131] Simon Heath,et al. Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis. , 2010, Journal of Alzheimer's disease : JAD.
[132] H. Haapasalo,et al. CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques , 2011, Alzheimer's Research & Therapy.
[133] L. Fratiglioni,et al. Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.